array(3) { ["company_details"]=> array(13) { ["name"]=> string(24) "Idexx Laboratories, Inc." ["slug"]=> string(31) "52dfe-us-idexx-laboratories-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/adce9a3c-023b-4043-9c56-fbed7dab6f62" ["description"]=> string(1658) "10,000 people, one global focus - enhancing the health and well-being of pets, people, and livestock We are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of disease, it’s no wonder that what we do each day is more than just a job. There’s an energy across IDEXX that is contagious – where caring and committed people come together to make things better.  IDEXX Laboratories, Inc. (NASDAQ: IDXX), a member of the S&P 500, is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. Headquartered in southern Maine, we conduct operations through more than 70 locations around the world and serve customers in over 175 countries. Our primary business focuses on pet health, a growing market around the world. Our products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. We also develop and manufacture diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water and milk. Please visit our website, IDEXX.com/careers, for further information and to view all of our job opportunities." ["address_street"]=> string(10) "1 Idexx Dr" ["address_place"]=> string(9) "Westbrook" ["address_region"]=> string(5) "Maine" ["founding_date"]=> string(10) "1983-02-28" ["website_domain"]=> string(9) "idexx.com" ["website_url"]=> string(21) "https://www.idexx.com" ["industry_codes"]=> array(4) { [0]=> string(43) "General Livestock, Except Dairy and Poultry" [1]=> string(33) "Veterinary Services for Livestock" [2]=> string(27) "Pharmaceutical Preparations" [3]=> string(42) "In Vitro and In Vivo Diagnostic Substances" } ["employee_count"]=> int(710) ["article_count"]=> int(640) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(84) "Will Avid Bioservices (USA Stocks:CDMO) investors shift to IDEXX (USA Stocks:IDXX)?" ["snippet_en"]=> string(295) "Despite Avid Bioservices' (USA Stocks: CDMO) current market capitalization of $400.9M and Wall Street's target price of $12.25, the company's financial health raises concerns due to its EBITDA showing a loss of $501K and a negative operating margin of -0.44. Given these factors, investors might" ["url"]=> string(131) "https://www.macroaxis.com/invest/story/CDMO/31258361/Will-Avid-Bioservices-USA-Stocks-CDMO-investors-shift-to-IDEXX-USA-Stocks-IDXX" ["image_url"]=> string(78) "https://images.businessradar.com/articles/72c924fb-8278-46f6-8a41-59e4046dc4fa" ["source"]=> string(13) "macroaxis.com" ["publication_date"]=> string(10) "2024-04-07" ["categories"]=> array(3) { [0]=> string(12) "Stock Market" [1]=> string(9) "Investors" [2]=> string(15) "Market Movement" } } [1]=> array(7) { ["title_en"]=> string(76) "IDEXX Laboratories shares cannot maintain previous day's level (€490.9692)" ["snippet_en"]=> string(131) "The shares of IDEXX Laboratories were trading slightly lighter on Thursday. Most recently, investors paid $534.42 for the security." ["url"]=> string(95) "https://www.ariva.de/news/aktie-von-idexx-laboratories-kann-vortagsniveau-nicht-halten-11177664" ["image_url"]=> string(78) "https://images.businessradar.com/articles/7cf0aa94-7659-4b52-bf2f-749377a604e0" ["source"]=> string(8) "ariva.de" ["publication_date"]=> string(10) "2024-03-14" ["categories"]=> array(2) { [0]=> string(12) "Stock Market" [1]=> string(24) "Stock Research & Ratings" } } [2]=> array(7) { ["title_en"]=> string(75) "IDEXX Laboratories Inc. stock outperforms competitors on strong trading day" ["snippet_en"]=> string(160) "Shares of IDEXX Laboratories Inc. inched 0.65% higher to $554.77 Wednesday, on what proved to be an all-around positive trading session for the stock market,..." ["url"]=> string(134) "https://www.marketwatch.com/data-news/idexx-laboratories-inc-stock-outperforms-competitors-on-strong-trading-day-f442fe29-21b7aab24909" ["image_url"]=> string(78) "https://images.businessradar.com/articles/136729fc-81a0-4fc5-be78-c72c4c56f6a4" ["source"]=> string(15) "marketwatch.com" ["publication_date"]=> string(10) "2024-02-21" ["categories"]=> array(3) { [0]=> string(12) "Stock Market" [1]=> string(24) "Stock Research & Ratings" [2]=> string(15) "Market Movement" } } [3]=> array(7) { ["title_en"]=> string(78) "IDEXX Labs cut to Neutral at Piper Sandler – ‘Stock needs volume upside’" ["snippet_en"]=> string(78) "IDEXX Labs cut to Neutral at Piper Sandler – ‘Stock needs volume upside’" ["url"]=> string(131) "https://ph.investing.com/news/stock-market-news/idexx-labs-cut-to-neutral-at-piper-sandler--stock-needs-volume-upside-432SI-1107651" ["image_url"]=> NULL ["source"]=> string(13) "investing.com" ["publication_date"]=> string(10) "2024-01-30" ["categories"]=> array(1) { [0]=> string(12) "Stock Market" } } [4]=> array(7) { ["title_en"]=> string(94) "Achmea Investment Management B.V. Buys 10,380 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)" ["snippet_en"]=> string(299) "Achmea Investment Management B.V. raised its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 98.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 20,957 shares of the company's stock after acquiring an" ["url"]=> string(76) "https://www.marketbeat.com/instant-alerts/nasdaq-idxx-sec-filing-2024-01-25/" ["image_url"]=> NULL ["source"]=> string(14) "marketbeat.com" ["publication_date"]=> string(10) "2024-01-25" ["categories"]=> array(8) { [0]=> string(20) "Corporate Governance" [1]=> string(11) "Regulations" [2]=> string(22) "Purchasing contracting" [3]=> string(12) "Stock Market" [4]=> string(14) "Issuing Shares" [5]=> string(18) "General Investment" [6]=> string(16) "Share Repurchase" [7]=> string(11) "Acquisition" } } [5]=> array(7) { ["title_en"]=> string(85) "IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Purchased by Corient Private Wealth LLC" ["snippet_en"]=> string(299) "Corient Private Wealth LLC lifted its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 3.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 132,470 shares of the company's stock after purchasing an additional 4,224 shares" ["url"]=> string(76) "https://www.marketbeat.com/instant-alerts/nasdaq-idxx-sec-filing-2024-01-24/" ["image_url"]=> NULL ["source"]=> string(14) "marketbeat.com" ["publication_date"]=> string(10) "2024-01-24" ["categories"]=> array(8) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(11) "Regulations" [2]=> string(12) "Stock Market" [3]=> string(14) "Issuing Shares" [4]=> string(24) "Stock Research & Ratings" [5]=> string(18) "General Investment" [6]=> string(16) "Share Repurchase" [7]=> string(24) "Quarterly/Annual Figures" } } [6]=> array(7) { ["title_en"]=> string(85) "Machina Capital S.A.S. Purchases New Shares in IDEXX Laboratories, Inc. (NASDAQ:IDXX)" ["snippet_en"]=> string(300) "Machina Capital S.A.S. purchased a new stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 2,705 shares of the company's stock, valued at approximately $1,183,000. A numb" ["url"]=> string(76) "https://www.marketbeat.com/instant-alerts/nasdaq-idxx-sec-filing-2024-01-21/" ["image_url"]=> NULL ["source"]=> string(14) "marketbeat.com" ["publication_date"]=> string(10) "2024-01-21" ["categories"]=> array(8) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(11) "Regulations" [2]=> string(12) "Stock Market" [3]=> string(14) "Issuing Shares" [4]=> string(24) "Stock Research & Ratings" [5]=> string(18) "General Investment" [6]=> string(16) "Share Repurchase" [7]=> string(11) "Acquisition" } } [7]=> array(7) { ["title_en"]=> string(83) "Duality Advisers LP Invests $1.98 Million in IDEXX Laboratories, Inc. (NASDAQ:IDXX)" ["snippet_en"]=> string(300) "Duality Advisers LP purchased a new position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 4,535 shares of the company's stock, valued at ap" ["url"]=> string(76) "https://www.marketbeat.com/instant-alerts/nasdaq-idxx-sec-filing-2024-01-20/" ["image_url"]=> NULL ["source"]=> string(14) "marketbeat.com" ["publication_date"]=> string(10) "2024-01-20" ["categories"]=> array(4) { [0]=> string(12) "Stock Market" [1]=> string(11) "Regulations" [2]=> string(19) "Investment Requests" [3]=> string(18) "General Investment" } } [8]=> array(7) { ["title_en"]=> string(107) "Investors are avoiding the IDEXX Laboratories share today: the price is falling significantly (€491.1639)" ["snippet_en"]=> string(120) "One of the big losers on the stock market today is IDEXX Laboratories shares. The security loses significantly in value." ["url"]=> string(92) "https://www.ariva.de/news/investoren-meiden-heute-die-idexx-laboratories-aktie-kurs-11111817" ["image_url"]=> string(78) "https://images.businessradar.com/articles/383ee36d-3455-4346-97ab-7ac95c8253ef" ["source"]=> string(8) "ariva.de" ["publication_date"]=> string(10) "2024-01-12" ["categories"]=> array(7) { [0]=> string(21) "Shareholders Feedback" [1]=> string(15) "Market Movement" [2]=> string(12) "Stock Market" [3]=> string(24) "Stock Research & Ratings" [4]=> string(18) "General Investment" [5]=> string(21) "Competitive Behaviour" [6]=> string(9) "Investors" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(117) } [1]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(65) } [2]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(43) } [3]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(43) } [4]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(40) } [5]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(24) } [6]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(22) } [7]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(22) } [8]=> array(2) { ["name"]=> string(12) "Restatements" ["count"]=> int(21) } [9]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(19) } [10]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(18) } [11]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(16) } [12]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(14) } [13]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(12) } [14]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(9) } [15]=> array(2) { ["name"]=> string(9) "Investors" ["count"]=> int(9) } [16]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(8) } [17]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(8) } [18]=> array(2) { ["name"]=> string(31) "Water and Wastewater Management" ["count"]=> int(7) } [19]=> array(2) { ["name"]=> string(16) "Share Repurchase" ["count"]=> int(7) } [20]=> array(2) { ["name"]=> string(19) "Economic Conditions" ["count"]=> int(7) } [21]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(7) } [22]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(7) } [23]=> array(2) { ["name"]=> string(13) "Credit Rating" ["count"]=> int(6) } [24]=> array(2) { ["name"]=> string(10) "New Market" ["count"]=> int(6) } [25]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(5) } [26]=> array(2) { ["name"]=> string(15) "Blogs & Columns" ["count"]=> int(5) } [27]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(5) } [28]=> array(2) { ["name"]=> string(20) "Corporate Governance" ["count"]=> int(5) } [29]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(5) } } } 52dfe-us-idexx-laboratories-inc